Drug
Who makes riociguat?
2 companies list riociguat as a human prescription drug, including under the names Adempas. Forms: tablet, film coated. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing riociguat
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Bayer Healthcare Manufacturing SrlGermany | tablet, film coated | NDANDA204819 | 5 | 13 |
| Zydus Pharmaceuticals USA Inc.India | tablet, film coated | ANDAANDA211135 | 5 | 1 |
Bulk ingredient listings
- Alembic Pharmaceuticals LimitedIndia · 1 NDC
- MSN Life Sciences Private LimitedIndia · 1 NDC
Orange Book patents
4 unexpired patents list riociguat as the active ingredient, expiring between Dec 2026 and Feb 2034. Application holder: BAYER HEALTHCARE PHARMACEUTICALS INC.
Enquiry
Common questions
- Who makes riociguat?
- 2 companies list riociguat as a human prescription drug in the openFDA NDC Directory, led by Bayer Healthcare Manufacturing Srl, Zydus Pharmaceuticals USA Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic Adempas?
- 1 company lists riociguat under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
- Who supplies riociguat active ingredient?
- 2 companies list riociguat as a bulk ingredient, including Alembic Pharmaceuticals Limited, MSN Life Sciences Private Limited.